Comparison of Figulla Flex ® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.

CONCLUSIONS: Percutaneous closure of ASD is a safe and effective, irrespective of the type of device. No differences exist regarding procedural success between the ASO and FSO devices but the last was associated to shorter procedure time, less radiation, and lower rate of supraventricular arrhythmias in follow-up. Late cardiac perforation did not occur and death in the follow-up was exceptional.
PMID: 32329042 [PubMed - as supplied by publisher]

Source: Cardiology Journal - April 23, 2020 Category: Cardiology Authors: Aparisi A, Arnold RJ, Gutiérrez H, Revilla A, Serrador A, Ramos B, Rodriguez-Gabella T, Campo A, Baladron C, Gómez I, Carrasco-Moraleja M, San Roman JA, Amat-Santos IJ Tags: Cardiol J Source Type: research